DE
MRK icon

DV Equities’s Merck MRK Stock Holding History

DV Equities’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$365K Buy
+3,468
New +$326K 0.07% 86

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DV Equities's MRK Position: Q4 2025 in Review

DV Equities opened a new position in Merck (MRK) in Q4 2025: 3,468 shares worth $365K. The stake represents 0.07% of the portfolio and ranks #86 among its holdings.

3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • DV Equities held 3,468 shares of Merck worth $365K as of Q4 2025.
  • Merck was a new DV Equities position in Q4 2025.
  • Merck made up 0.07% of DV Equities's portfolio in Q4 2025, its #86 holding.
  • 3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on DV Equities's 13F filing for Q4 2025, filed 17 Feb 2026.